A Tissue Therapeutics Revolution
3 days ago
- #biotechnology
- #regenerative-medicine
- #skin-therapeutics
- CUTISS is a late-stage clinical TechBio company specializing in skin tissue therapeutics.
- denovoSkin™ is their first-in-class personalized tissue therapy for automated, on-demand production of living skin.
- denovoSkin™ is designed for patients needing skin surgery, showing long-term safety and efficacy.
- CUTISS has developed a scalable, automated production platform for personalized tissue therapy.
- The platform supports decentralized production, cost-effective scale-up, and high ROI.
- Potential applications include regenerative medicine, Space Health research, and industrial bioengineered tissues.